Rigel Pharma (RIGL)
1.13
-0.01 (0.88%)
Upcoming Events
Latest Headlines
Form 8-K RIGEL PHARMACEUTICALS For: Apr 11
April 12, 2024 8:06 AM - SEC Filing
Form ARS RIGEL PHARMACEUTICALS For: Dec 31
April 10, 2024 5:30 PM - SEC Filing
Form DEFA14A RIGEL PHARMACEUTICALS
April 10, 2024 4:51 PM - SEC Filing
Form DEF 14A RIGEL PHARMACEUTICALS For: May 22
April 10, 2024 4:50 PM - SEC Filing
Rigel Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
April 10, 2024 4:30 PM - PR NewsWire
Rigel Pharma (RIGL) Announces Publication of Data on REZLIDHIA
April 4, 2024 8:06 AM - StreetInsider
Rigel Announces Publication of Data on REZLIDHIA® (Olutasidenib) in Post-Venetoclax Patients with Mutant IDH1 AML in Leukemia & Lymphoma
April 4, 2024 8:05 AM - PR NewsWire
Form PRE 14A RIGEL PHARMACEUTICALS For: May 22
March 29, 2024 5:05 PM - SEC Filing
Form 4 RIGEL PHARMACEUTICALS For: Mar 27 Filed by: Rojkjaer Lisa
March 29, 2024 4:09 PM - SEC Filing
Form 3 RIGEL PHARMACEUTICALS For: Mar 27 Filed by: Rojkjaer Lisa
March 29, 2024 4:05 PM - SEC Filing
Rigel Pharma (RIGL) Announces Appointment of Lisa Rojkjaer, M.D. as Chief Medical Officer
March 12, 2024 8:05 AM - StreetInsider
Rigel Pharmaceuticals Announces Appointment of Lisa Rojkjaer, M.D. as Chief Medical Officer
March 12, 2024 8:05 AM - PR NewsWire
Form 8-K RIGEL PHARMACEUTICALS For: Mar 05
March 5, 2024 4:11 PM - SEC Filing
Form 10-K RIGEL PHARMACEUTICALS For: Dec 31
March 5, 2024 4:07 PM - SEC Filing
Rigel Pharma (RIGL) Tops Q4 EPS by 2c, Tops on Revenue
March 5, 2024 4:02 PM - StreetInsider
Rigel Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
March 5, 2024 4:01 PM - PR NewsWire
Form 4 RIGEL PHARMACEUTICALS For: Feb 28 Filed by: Schorno Dean L
March 1, 2024 7:16 PM - SEC Filing
Form 4 RIGEL PHARMACEUTICALS For: Feb 28 Filed by: Santos David A
March 1, 2024 7:16 PM - SEC Filing
Form 4 RIGEL PHARMACEUTICALS For: Feb 28 Filed by: RODRIGUEZ RAUL R
March 1, 2024 7:15 PM - SEC Filing
Form 4 RIGEL PHARMACEUTICALS For: Feb 28 Filed by: Furey Raymond J.
March 1, 2024 7:15 PM - SEC Filing
Rigel Announces Conference Call and Webcast to Report Fourth Quarter and Full Year 2023 Financial Results and Business Update
February 27, 2024 8:05 AM - PR NewsWire
Rigel Pharmaceuticals (RIGL) PT Raised to $1.75 at B.Riley
February 26, 2024 8:15 AM - StreetInsider
Form 8-K RIGEL PHARMACEUTICALS For: Feb 22
February 22, 2024 8:01 AM - SEC Filing
Rigel Pharma (RIGL) Acquires U.S. Rights to GAVRETO from Blueprint Medicines (BPMC)
February 22, 2024 7:51 AM - StreetInsider
Rigel Pharmaceuticals Acquires U.S. Rights to GAVRETO®
February 22, 2024 7:50 AM - PR NewsWire
Form SC 13G/A RIGEL PHARMACEUTICALS Filed by: ARMISTICE CAPITAL, LLC
February 14, 2024 2:30 PM - SEC Filing
Form SC 13G/A RIGEL PHARMACEUTICALS Filed by: VANGUARD GROUP INC
February 13, 2024 6:12 PM - SEC Filing
Form SC 13G RIGEL PHARMACEUTICALS Filed by: MORGAN STANLEY
February 9, 2024 12:17 PM - SEC Filing
Form 4 RIGEL PHARMACEUTICALS For: Feb 02 Filed by: Santos David A
February 6, 2024 8:19 PM - SEC Filing
Form 4 RIGEL PHARMACEUTICALS For: Feb 02 Filed by: Schorno Dean L
February 6, 2024 8:19 PM - SEC Filing
Form 4 RIGEL PHARMACEUTICALS For: Feb 02 Filed by: RODRIGUEZ RAUL R
February 6, 2024 8:18 PM - SEC Filing
Form SC 13G/A RIGEL PHARMACEUTICALS Filed by: GOLDMAN SACHS GROUP INC
February 5, 2024 5:35 PM - SEC Filing
Form SC 13G/A RIGEL PHARMACEUTICALS Filed by: Soleus Capital Master Fund, L.P.
February 2, 2024 9:56 AM - SEC Filing
Full Article List
